- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06859060
Improving Health and Wellness for People With Serious Mental Illness in Puerto Rico (BRIDGES)
Testing Bridges to Better Health and Wellness for People Living With Serious Mental Illness in Puerto Rico
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eliut Rivera-Segarra, PhD
- Phone Number: 787-840-2575
- Email: elrivera@psm.edu
Study Contact Backup
- Name: Nelmit Tollinchi, PhD
- Phone Number: 939-905-0420
- Email: bridgespr@psm.edu
Study Locations
-
-
Puerto Rico
-
Mayagüez, Puerto Rico, Puerto Rico, 00681
- Recruiting
- Mayagüez Medical Center Primary Care Psychology Clinic
-
Principal Investigator:
- Eliut Rivera-Segarra, PhD
-
Contact:
- Nelmit Tollinchi, PhD
- Phone Number: 939-905-0420
- Email: bridgespr@psm.edu
-
Ponce, Puerto Rico, Puerto Rico, 00716
- Recruiting
- PHSU Wellness Center
-
Principal Investigator:
- Eliut Rivera-Segarra, PhD
-
Contact:
- Nelmit Tollinchi, PhD
- Phone Number: 939-905-0420
- Email: bridgespr@psm.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
Adults receiving psychiatric or psychological services at the Wellness Center or the Mayaguez Medical Center - Primary Care Diagnosed with at least one serious mental illness SMI (e.g., schizophrenia, bipolar disorder, major depression, etc.) Have at least one risk factor or a diagnosis of a chronic health condition (e.g., diabetes, overweight, hypertension, etc.).
Be willing to receive or continue preventive medical care with a primary care physician.
Exclusion criteria:
Have started psychiatric or mental health services at least one month before Have been diagnosed with a general mental health condition (e.g., Depression or Anxiety).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BRIDGES Intervention
Participants randomized to the experimental condition will receive the BRIDGES Healthcare Manager Intervention.
|
A culturally adapted, multilevel intervention consisting of monthly 60-minute sessions over a 12-month period.
Sessions will be conducted by graduate clinical psychology students acting as healthcare managers.
The intervention focuses on care coordination, patient activation, and reducing provider stigma to improve access to preventive primary care services.
|
|
Other: Enhanced Treatment as Usual (ETAU)
Participants randomized to the control condition will receive standard psychiatric care with an informational brochure on accessing primary care providers.
|
Participants will continue to receive standard psychiatric care, including routine visits with their mental health providers at the designated clinical sites.
They will also receive a booklet with information on how best to link with primary care providers.
This ensures that participants are aware of available resources and basic health care recommendations, but does not include any active follow-up or intervention components.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recipt of Preventive Primary Care
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
29-item questionnaire developed by team members.
It uses preventive primary care indicators from the US Preventive Service Task Force Guidelines extracted from medical records and examines the use of physical health services over the past 6-months.Indicators are grouped into six categories: physical examinations, screenings for women, screenings for men, laboratory tests, vaccinations, and education.
An aggregate preventive primary score is calculated representing the proportion of services for which each participant was eligible depending on age and gender.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin A1c
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
The A1C test is a simple common blood test used to measure blood sugar levels over the past 3 months.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Lipid Panel
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
The Lipid panel is a simple common blood test used to examine cardiovascular health by analyzing cholesterol in the blood.
This test examines four types of lipids in the blood, namely: 1) Total cholesterol, 2 Low-density lipoprotein (LDL), 3) High-density lipoprotein (HDL), and 4) Triglycerides.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Basic Metabolic Panel
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
It is a simple common blood group of tests used to examine different naturally occurring chemicals in the blood.
The tests can give information heart, kidneys, and liver function.
It includes Blood urine nitrogen (BUN), carbon dioxide (C02), Creatinine, Glucose, Serum chloride, Serum potassium, Serum sodium, and Serum Calcium.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Smoking - Severity Dependence Scale
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
Five-item scale, used to assess severity of smoking.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Physical Activity - International Physical Activity Questionnaire
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
This is a 7-item measure widely used to examine 4 types of physical activity: 1) vigorous, 2) moderate, 3) walking and 4) sitting.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Health Literacy - Test of Functional Health Literacy for Adults
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
Questionnaire with 12 items measuring adult functional health literacy in the health care setting.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Self-Stigma - Self-Stigma of Mental Illness Scale
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
This 40-item measure examines self stigma's four dimensions (awareness, agreement, self-application and self esteem).
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Provider Stigma - The Mental Health Stigma Scale for Health Professionals
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
12-item measure examining provider stigma dimensions (social distance, negative character attributions and self-sufficiency).
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
|
Patient-Provider Relationship - Patient Assessment of Chronic Illness Care
Time Frame: baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
20-item scale used to assess participants' perspectives on the quality and patient-centeredness of chronic illness care received during the past 6 months from their primary care provider.
|
baseline,6 and 12 months follow up and 6 and 12 months post intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2308159485
- 2U54MD007579-39 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.